| SC 13G/A | 2022-02-10 | Invesco Ltd. | REATA PHARMACEUTICALS INC | 2,280,409 | 7.2% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | REATA PHARMACEUTICALS INC | 2,557,673 | 8.1% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | REATA PHARMACEUTICALS INC | 4,252,977 | 13.5% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | REATA PHARMACEUTICALS INC | 2,114,050 | 6.7% | EDGAR |
| SC 13G/A | 2021-09-10 | Invesco Ltd. | REATA PHARMACEUTICALS INC | 3,437,578 | 10.9% | EDGAR |
| SC 13G | 2021-02-16 | Invesco Ltd. | REATA PHARMACEUTICALS INC | 1,779,475 | 5.7% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | REATA PHARMACEUTICALS INC | 2,320,031 | 7.5% | EDGAR |
| SC 13G/A | 2021-02-04 | WELLINGTON MANAGEMENT GROUP LLP | REATA PHARMACEUTICALS INC | 4,345,724 | 14.0% | EDGAR |
| SC 13D/A | 2020-12-30 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,589,758 | 14.0% | EDGAR |
| SC 13D/A | 2020-12-09 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,215,700 | 9.7% | EDGAR |
| SC 13G/A | 2020-10-09 | BlackRock Inc. | REATA PHARMACEUTICALS INC | 1,376,084 | 4.8% | EDGAR |
| SC 13G/A | 2020-04-09 | WELLINGTON MANAGEMENT GROUP LLP | REATA PHARMACEUTICALS INC | 3,020,924 | 10.8% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | REATA PHARMACEUTICALS INC | 2,166,886 | 7.9% | EDGAR |
| SC 13G/A | 2020-02-06 | BlackRock Inc. | REATA PHARMACEUTICALS INC | 2,243,871 | 8.2% | EDGAR |
| SC 13G | 2020-01-28 | WELLINGTON MANAGEMENT GROUP LLP | REATA PHARMACEUTICALS INC | 2,392,674 | 8.7% | EDGAR |
| SC 13D/A | 2019-11-20 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,207,181 | 10.8% | EDGAR |
| SC 13G | 2019-02-12 | VANGUARD GROUP INC | REATA PHARMACEUTICALS INC | 1,258,234 | 5.2% | EDGAR |
| SC 13G/A | 2019-02-06 | BlackRock Inc. | REATA PHARMACEUTICALS INC | 1,958,164 | 8.2% | EDGAR |
| SC 13D/A | 2018-11-14 | ROSE WILLIAM | REATA PHARMACEUTICALS INC | 3,197,213 | 12.2% | EDGAR |
| SC 13D/A | 2018-07-31 | CPMG Inc | REATA PHARMACEUTICALS INC | 4,605,380 | 18.1% | EDGAR |